Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study)-Correspondence
- PMID: 32857329
- DOI: 10.1007/s12098-020-03461-2
Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study)-Correspondence
Comment on
-
Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study).Indian J Pediatr. 2021 Mar;88(3):240-245. doi: 10.1007/s12098-020-03377-x. Epub 2020 Jun 15. Indian J Pediatr. 2021. PMID: 32537711 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical